783 related articles for article (PubMed ID: 20049366)
1. Iron deficiency and anaemia in bariatric surgical patients: causes, diagnosis and proper management.
Muñoz M; Botella-Romero F; Gómez-Ramírez S; Campos A; García-Erce JA
Nutr Hosp; 2009; 24(6):640-54. PubMed ID: 20049366
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
Geisser P; Banké-Bochita J
Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
Geisser P; Rumyantsev V
Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
[TBL] [Abstract][Full Text] [Related]
4. Obesity, bariatric surgery, and iron deficiency: true, true, true and related.
Love AL; Billett HH
Am J Hematol; 2008 May; 83(5):403-9. PubMed ID: 18061940
[TBL] [Abstract][Full Text] [Related]
5. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
[TBL] [Abstract][Full Text] [Related]
6. [Iron deficiency in ND-CKD: from diagnosis to treatment].
Liberti ME; Garofalo C; Sagliocca A; Borrelli S; Conte G; De Nicola L; Minutolo R
G Ital Nefrol; 2017 Sep; 34(5):50-61. PubMed ID: 28963827
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
Qunibi WY
Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
[TBL] [Abstract][Full Text] [Related]
8. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients.
Malone M; Barish C; He A; Bregman D
Obes Surg; 2013 Sep; 23(9):1413-20. PubMed ID: 23553506
[TBL] [Abstract][Full Text] [Related]
9. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
[TBL] [Abstract][Full Text] [Related]
10. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA
BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286
[TBL] [Abstract][Full Text] [Related]
11. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia.
Calvet X; Gené E; ÀngelRuíz M; Figuerola A; Villoria A; Cucala M; Mearin F; Delgado S; Calleja JL
Technol Health Care; 2016; 24(1):111-20. PubMed ID: 26409561
[TBL] [Abstract][Full Text] [Related]
12. Ferric carboxymaltose: a review of its use in iron deficiency.
Keating GM
Drugs; 2015 Jan; 75(1):101-27. PubMed ID: 25428711
[TBL] [Abstract][Full Text] [Related]
13. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
[TBL] [Abstract][Full Text] [Related]
14. When is high-dose intravenous iron repletion needed? Assessing new treatment options.
Gozzard D
Drug Des Devel Ther; 2011 Jan; 5():51-60. PubMed ID: 21340038
[TBL] [Abstract][Full Text] [Related]
15. Anemia after bariatric surgery: more than just iron deficiency.
von Drygalski A; Andris DA
Nutr Clin Pract; 2009; 24(2):217-26. PubMed ID: 19321896
[TBL] [Abstract][Full Text] [Related]
16. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
Cases Amenós A; Ojeda López R; Portolés Pérez JM;
Nefrologia; 2017; 37(6):587-591. PubMed ID: 28610806
[TBL] [Abstract][Full Text] [Related]
17. Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
[TBL] [Abstract][Full Text] [Related]
18. [Is intravenous iron really useful in inflammatory bowel disease? Would oral iron not be simpler and cheaper?].
Bermejo San José F
Gastroenterol Hepatol; 2009 Jan; 32(1):63-4. PubMed ID: 19174104
[No Abstract] [Full Text] [Related]
19. Iron deficiency before and after bariatric surgery: the need for iron supplementation.
ten Broeke R; Bravenboer B; Smulders FJ
Neth J Med; 2013 Oct; 71(8):412-7. PubMed ID: 24127501
[TBL] [Abstract][Full Text] [Related]
20. Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study.
Viethen T; Gerhardt F; Dumitrescu D; Knoop-Busch S; ten Freyhaus H; Rudolph TK; Baldus S; Rosenkranz S
Int J Cardiol; 2014 Aug; 175(2):233-9. PubMed ID: 24880481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
